BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 10574502)

  • 1. Fetal RhD genotyping from maternal plasma.
    Lo YM
    Ann Med; 1999 Oct; 31(5):308-12. PubMed ID: 10574502
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prenatal diagnosis of fetal RhD status by molecular analysis of maternal plasma.
    Lo YM; Hjelm NM; Fidler C; Sargent IL; Murphy MF; Chamberlain PF; Poon PM; Redman CW; Wainscoat JS
    N Engl J Med; 1998 Dec; 339(24):1734-8. PubMed ID: 9845707
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Accuracy of prenatal determination of RhD type status by polymerase chain reaction with amniotic cells.
    Lighten AD; Overton TG; Sepulveda W; Warwick RM; Fisk NM; Bennett PR
    Am J Obstet Gynecol; 1995 Oct; 173(4):1182-5. PubMed ID: 7485316
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-invasive prenatal determination of fetal RhD genotyping from maternal plasma: a preliminary study in Pakistan.
    Mohammed N; Kakal F; Somani M; Zafar W
    J Coll Physicians Surg Pak; 2010 Apr; 20(4):246-9. PubMed ID: 20392400
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RHD genotyping from maternal plasma: guidelines and technical challenges.
    Avent ND
    Methods Mol Biol; 2008; 444():185-201. PubMed ID: 18425481
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Noninvasive prenatal diagnosis from maternal plasma in serological conflicts in Poland: current practice and future prospects].
    Orzińska A; Guz K; Brojer E
    Ginekol Pol; 2009 Oct; 80(10):768-71. PubMed ID: 19943542
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The determination of the fetal D status from maternal plasma for decision making on Rh prophylaxis is feasible.
    Müller SP; Bartels I; Stein W; Emons G; Gutensohn K; Köhler M; Legler TJ
    Transfusion; 2008 Nov; 48(11):2292-301. PubMed ID: 18694461
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fetal RhD genotyping by analysis of maternal blood. A case report.
    Tóth T; Papp C; Tóth-Pál E; Nagy B; Papp Z
    J Reprod Med; 1998 Mar; 43(3):219-22. PubMed ID: 9564650
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fetal RHD genotyping in maternal serum during the first trimester of pregnancy.
    Costa JM; Giovangrandi Y; Ernault P; Lohmann L; Nataf V; El Halali N; Gautier E
    Br J Haematol; 2002 Oct; 119(1):255-60. PubMed ID: 12358932
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prenatal genotyping of RHD and SRY using maternal blood.
    Randen I; Hauge R; Kjeldsen-Kragh J; Fagerhol MK
    Vox Sang; 2003 Nov; 85(4):300-6. PubMed ID: 14633256
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prenatal typing of Rh and Kell blood group system antigens: the edge of a watershed.
    van der Schoot CE; Tax GH; Rijnders RJ; de Haas M; Christiaens GC
    Transfus Med Rev; 2003 Jan; 17(1):31-44. PubMed ID: 12522770
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic accuracy of noninvasive fetal Rh genotyping from maternal blood--a meta-analysis.
    Geifman-Holtzman O; Grotegut CA; Gaughan JP
    Am J Obstet Gynecol; 2006 Oct; 195(4):1163-73. PubMed ID: 17000250
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of prenatal RHD typing strategies on cell-free fetal DNA from maternal plasma.
    Grootkerk-Tax MG; Soussan AA; de Haas M; Maaskant-van Wijk PA; van der Schoot CE
    Transfusion; 2006 Dec; 46(12):2142-8. PubMed ID: 17176327
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Routine testing of fetal Rhesus D status in Rhesus D negative women using cell-free fetal DNA: an investigation into the preferences and information needs of women.
    Oxenford K; Silcock C; Hill M; Chitty L
    Prenat Diagn; 2013 Jul; 33(7):688-94. PubMed ID: 23625761
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent developments in fetal nucleic acids in maternal plasma: implications to noninvasive prenatal fetal blood group genotyping.
    Lo YM
    Transfus Clin Biol; 2006; 13(1-2):50-2. PubMed ID: 16563836
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Evaluation of conventional hemi nested PCR analysis for fetal RHD determination in maternal plasma].
    Dif-Couvreux D; Houfflin-Debarge V; Delsalle A; Dourieux S; Dubreucq S; Manessier L; Puech F
    J Gynecol Obstet Biol Reprod (Paris); 2006 Nov; 35(7):658-64. PubMed ID: 17088765
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Noninvasive determination of fetal RhD status using fetal DNA in maternal serum and PCR.
    Bischoff FZ; Nguyen DD; Marquéz-Do D; Moise KJ; Simpson JL; Elias S
    J Soc Gynecol Investig; 1999; 6(2):64-9. PubMed ID: 10205775
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical utility of fetal RhD typing in alloimmunized pregnancies by means of polymerase chain reaction on amniocytes or chorionic villi.
    Fisk NM; Bennett P; Warwick RM; Letsky EA; Welch R; Vaughan JI; Moore G
    Am J Obstet Gynecol; 1994 Jul; 171(1):50-4. PubMed ID: 8030733
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prenatal determination of fetal rhesus D status by DNA amplification of peripheral blood of rhesus-negative mothers.
    Lo YM; Bowell PJ; Selinger M; Mackenzie IZ; Chamberlain P; Gillmer MD; Elliott P; Pratt G; Littlewood TJ; Fleming KA
    Ann N Y Acad Sci; 1994 Sep; 731():229-36. PubMed ID: 7944125
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prediction of fetal Rh D and Rh CcEe phenotype from maternal plasma with real-time polymerase chain reaction.
    Legler TJ; Lynen R; Maas JH; Pindur G; Kulenkampff D; Suren A; Osmers R; Köhler M
    Transfus Apher Sci; 2002 Dec; 27(3):217-23. PubMed ID: 12509216
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.